Dhruvalkumar Patel takes 10.01% of Rekvina Laboratories via open offer
What's the deal? Dhruvalkumar Patel has acquired a 10.01% stake in Rekvina Laboratories LtdDealroom has a profile for this one. Try Dealroom →, or 11,12,562 equity shares. The purchase combined a preferential allotment of 2,22,562 shares on August 12, 2026, with an open offer for 8,90,000 shares on August 13, 2026.
Why now? The preferential allotment stems from a Share Exchange and Purchase Agreement dated March 16, 2026, pointing to a planned change in ownership. The filing follows SEBI's takeover regulations.
What changes now? Rekvina's equity capital has grown from Rs 3.01 crore, or 60,28,000 shares, to Rs 5.56 crore, or 1,11,15,750 shares, reflecting the new shares issued and acquired.
What could go wrong? The arrival of a major new shareholder could reshape management or strategic direction — shifts existing shareholders will want to watch.
The signal: A negotiated share agreement paired with an open offer marks a deliberate ownership shift at Rekvina, setting up Patel as a shareholder with the weight to influence the company's next moves.
Read more: WhalesBook
Image credit: foteih
